CV Lattes
ORCID
Abstract
Acute Myeloid Leukemia (AML) is a malignant disease that affects the myeloid progenitor cells of the bone marrow. It is a molecularly and clinically heterogeneous disease, what makes the prognostic variable and the treatment must cover this plurality of mutations. The most common treatment for AML is the conventional chemotherapy that objectives complete remission (CR). However, mutations…